Acadia Healthcare Reports 28.3% Growth in Fourth Quarter Adjusted EPS to $0.59 on Revenue of $495.3 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Trump says Canada's Bombardier must build jets in US or lose market access
- Wall St slips as Gulf tensions send oil to over six-week high
- European shares subdued as surging crude sharpens focus on ECB rate path
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Acadia (ACHC) Should Be Bought on CMA Enforcement Order Weakness - Mizuho
February 18, 2016 12:19 PM ESTMizuho Securities analyst Ann Hynes said reaction in Acadia Healthcare (NASDAQ: ACHC) to CMA enforcement order is overdone and they would be buyers on weakness.
Hynes commented, "The U.K.'s Competition and Markets Authority (CMA) served an initial enforcement order relating to... More
Acadia Healthcare (ACHC) PT, Estimates Cut at Jefferies
February 17, 2016 6:51 AM ESTJefferies analyst Brian Tanquilut lowered his price target on Acadia Healthcare (NASDAQ: ACHC) to $85.00 (from $100.00) but maintained a Buy rating.
Tanquilut commented, "Our thesis on ACHC (strong organic growth boosted by M&A, with optionality for Medicaid-driven upside) was further validated by... More
Acadia Healthcare (ACHC) Reports In-Line Q4 EPS, Offers Q1 & FY Guidance
February 16, 2016 4:14 PM ESTAcadia Healthcare (NASDAQ: ACHC) reported Q4 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $495.3 million versus the consensus estimate of $488 million.
GUIDANCE:
Acadia Healthcare sees Q1 2016 EPS of $0.53-$0.54, versus the consensus of... More
